Suicidal Ideation Clinical Trial
— BASOfficial title:
Brief Admission Skane: Can Brief Admission Replace General Admission for Individuals With Self-harm and Acute Risk of Suicide
Verified date | August 2018 |
Source | Region Skane |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to test a standardized version of brief admission (BA) through randomized controlled trial (RCT). The main objective is to evaluate if BA can serve as a crisis management model for individuals with recurrent self-harm, including suicide attempts and at least three symptoms of Borderline Personality disorder. Participants will be allocated to BA + Treatment as Usual (TAU) or TAU.
Status | Completed |
Enrollment | 125 |
Est. completion date | August 10, 2018 |
Est. primary completion date | June 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Current episodes of self-harm and/or recurrent suicidality. - Fulfilling at least three criteria for borderline personality disorder. - Admitted to psychiatric hospital for acute care for at least 7 days or presenting to the psychiatric emergency department at least 3 times during the last six months. Exclusion Criteria: - No regular contact with outpatient psychiatric services. - Homelessness. Housing crises are outside the scope of this RCT. - Medical disorder from other organs that significantly contributes to inclusion criteria (e.g. if self-harm only occurs during episodes of hypoglycemia in a diabetic patient). |
Country | Name | City | State |
---|---|---|---|
Sweden | Division of Psychiatry, Region Skåne | Lund | Skåne |
Lead Sponsor | Collaborator |
---|---|
Region Skane | Lund University, Radboud University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of days with hospital admission | Number of days with Brief admission, general admission, forced (involuntary) admission | Change between the period from 12 month retrospectively to Baseline and the period from baseline to 12 months prospectively | |
Secondary | Frequency of forced acts (e.g. restraints and forced medication) | Change between the period from 12 month retrospectively to Baseline and the period from baseline to 12 months prospectively | ||
Secondary | Individuals' Experiences of the intervention | Outcome from the questionnaires developed for the method: Individual's Experience Scale (IES) | Data collected at each Brief Admission during a period of 140 weeks. A Brief Admission is defined as a hospital admission according to the procedure defined in the Brief Admission Skane Standardised Protocol. | |
Secondary | Clinicians' Experiences of the intervention | Outcome from the questionnaires developed for the method: Clinician's Experience Scale (CES) | Data collected at each Brief Admission during a period of 140 weeks. A Brief Admission is defined as a hospital admission according to the procedure defined in the Brief Admission Skane Standardised Protocol. | |
Secondary | Frequency of all self-harming behaviours including suicide attempts | Outcome from Five Self-Harm Behaviour Groupings Measure (5S-HM) | Change in frequency between baseline, 6 months and 12 months prospectively. | |
Secondary | Severity of self-harming behaviours | Outcome from Five Self-Harm Behaviour Groupings Measure (5S-HM) | Change in severity between baseline, 6 months and 12 months prospectively. | |
Secondary | Level of functioning in activities of daily life | The World Health Organization Disability Assessment Schedule II (WHODAS 2.0) | Change in ratings between baseline, 6 months and 12 months prospectively. | |
Secondary | Ability to cope effectively with life stress | The Brief COPE | Change in ratings between baseline, 6 months and 12 months prospectively. | |
Secondary | Ability to regulate emotions | The Difficulties in Emotion Regulation Scale | Change in ratings between baseline, 6 months and 12 months prospectively. | |
Secondary | Global psychiatric symptoms | Outcome from Clinical Global Impression Severity Scale | Change in ratings between baseline, 6 months and 12 months prospectively. | |
Secondary | Satisfaction with health care | Client Satisfaction Questionnaire (CSQ) | Change in ratings between baseline, 6 months and 12 months prospectively. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05334381 -
Navigating Mental Health Treatment for Black Youth
|
N/A | |
Recruiting |
NCT04653337 -
Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression
|
Phase 2 | |
Terminated |
NCT04254809 -
Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts
|
N/A | |
Recruiting |
NCT05848089 -
Real-time Intervention for Suicide Risk Reduction
|
N/A | |
Recruiting |
NCT06322199 -
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
|
||
Completed |
NCT05280756 -
Home-based tDCS for Prevention of Suicidal Ideation
|
N/A | |
Not yet recruiting |
NCT06454136 -
Pilot Trial of Mobile Technology for Adolescent Suicidality
|
N/A | |
Completed |
NCT01944293 -
Ketamine for Suicidality in Bipolar Depression
|
Phase 1/Phase 2 | |
Completed |
NCT02021344 -
Mental Health First Aid for College Students
|
N/A | |
Not yet recruiting |
NCT04686162 -
Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy
|
N/A | |
Recruiting |
NCT05377177 -
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
|
N/A | |
Completed |
NCT05580757 -
Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
|
||
Recruiting |
NCT05925322 -
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
|
N/A | |
Not yet recruiting |
NCT05427734 -
Treating Drivers of Suicide Using Jaspr Health
|
N/A | |
Recruiting |
NCT04112368 -
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
|
Phase 4 | |
Completed |
NCT04026308 -
Written vs Electronic Safety Planning Study
|
N/A | |
Recruiting |
NCT05537376 -
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
|
N/A | |
Not yet recruiting |
NCT06311591 -
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B
|
N/A | |
Recruiting |
NCT05894980 -
How to Reduce Suicidal Thoughts and Impulsivity in Depression
|
N/A | |
Not yet recruiting |
NCT05860257 -
Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction
|
N/A |